Regulus Therapeutics Inc. clinical trials
Acquired by Novartis, Jun 25, 2025 · source ↗
The registry lists 3 studies whose lead sponsor is Regulus Therapeutics Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 27, 2025.
- 3studies on the registry
- 0open to participants now
Before and after it joined Novartis
- First submitted before Regulus Therapeutics Inc. became part of Novartis
- 3
- First submitted after Regulus Therapeutics Inc. became part of Novartis
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3100%
Over the years
- 20
- 21
- 222
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Regulus Therapeutics Inc.3 studies
Something wrong with this grouping? Tell us on the Novartis page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Novartis studies →
- A Study of RGLS8429 in Healthy VolunteersCompletedNCT05429073Phase 1
Sponsor listed in the registry: Regulus Therapeutics Inc. · First submitted before Regulus Therapeutics Inc. became part of Novartis
- A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05521191Phase 1
Sponsor listed in the registry: Regulus Therapeutics Inc. · First submitted before Regulus Therapeutics Inc. became part of Novartis
- A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04536688Phase 1
Sponsor listed in the registry: Regulus Therapeutics Inc. · First submitted before Regulus Therapeutics Inc. became part of Novartis